Biology has outpaced DNA supply.
Speed compounds value.
Earlier access to highly complex DNA enables more design cycles, faster clinical progression and earlier clinical entry.
Complexity enables new classes of technology.
Manufacturing capability defines technological possibility. When complexity becomes manufacturable at scale, novel modalities become viable and design freedom increases.
Leading therapeutics teams are already accelerating development with high-complexity DNA delivered in days not months.
Resilience is structural.
Concentrated supply chains introduce fragility. Our interconnected, deployable DNA infrastructure overcomes centralised constraints and capacity bottlenecks. Meeting demand is not just a commercial opportunity but a strategic necessity to ensuring sovereign security in the face of global shocks.
From difficult constructs to production-ready material, NunaBio enables rapid iteration across R&D and manufacturing workflows, ensuring sovereign security and supply chain resilience.
